PA

Pierre A Morgon

Non-Executive Director

Barinthus Biotherapeutics

Barinthus Biotherapeutics Pipeline

DrugIndicationPhase
VTP-300Chronic Hepatitis B (HBV)Phase 1b/2a
VTP-200Low-grade HPV-related cervical lesionsPhase 1b/2
SNAP-based ProgramCeliac DiseasePre-clinical